 For NPR News, I'm Jeff London. For only the second time, U.S. health officials are approving a new Alzheimer's drug that has shown a modest ability to slow the memory-destroying disease. The Food and Drug Administration approving the medicine made by Eli Lilly for patients with early or mild cases of dementia due to Alzheimer's. Drug called Kinsonla is not a cure, but is said to slow worsening memory and cognitive problems by around seven months.